Barclays »

Benitec Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $299k 21k 14.03
2025-06-30 $315k 27k 11.69

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
BlackRock
Nantahala Capital Management
Infinitum Asset Management
Geode Capital Management
Silverarc Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Goldman Sachs Group
AWM Investment Company
Ameriprise Financial

View all funds holding Benitec Biopharma